PARMAR KUSH - Insider Non-Derivative Transactions at Entrada Therapeutics, Inc. (TRDA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 14, 2025, PARMAR KUSH's relationship to Entrada Therapeutics, Inc. (TRDA) is Director,TenPercentOwner, and currently has 2,963,066 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRDA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

PARMAR KUSH - Insider Non-Derivative Transactions of TRDA Common Stock

PARMAR KUSH - Insider Non-Derivative Transactions at TRDA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 15, 2025	Sell -- (Common Stock)	200000	8.8	2963066
Jul 10, 2025	Sell -- (Common Stock)	6935	7.5	1093313
Jul 10, 2025	Sell -- (Common Stock)	20065	7.5	3163066
Jul 2, 2025	Sell -- (Common Stock)	6422	7.12	1100248
Jul 2, 2025	Sell -- (Common Stock)	18578	7.12	3183131
Jul 1, 2025	Sell -- (Common Stock)	6422	6.81	1106670
Jul 1, 2025	Sell -- (Common Stock)	18578	6.81	3201709
Jun 28, 2025	Sell -- (Common Stock)	19265	6.91	1113092
Jun 28, 2025	Sell -- (Common Stock)	55735	6.91	3220287